IL7R and glioblastoma: Additionally, we demonstrated the superior antitumor activity of B7H3 IL7R-S CAR-T cells in vivo compared to conventional second-generation B7H3 CAR-T cells in two distinct glioblastoma-bearing xenograft mouse models.